Scientists shocked by the Trump administration's "sledgehammer" wonder about possible motives and lament a short-sighted approach to cuts.

The government has funded science and then largely left well enough alone. Scientific agencies have been staffed by ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Africa is grappling with severe food insecurity in the wake of consecutive droughts, climate change, and ongoing conflicts, which are affecting millions across the continent.

According to the experts, humans will look a lot more uniform in the future. They predict the average person will have darker ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...

Explore the latest tech innovations, from AI and quantum computing to 5G and space travel. Stay updated with News Junction ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...